Literature DB >> 12607155

Refractive errors and cataract as causes of visual impairment in Brazil.

Carlos Eduardo Leite Arieta1, Alzira Maria Nicolini Delgado, Newton Kara José, Edméia Rita Temporini, Milton Ruiz Alves, Djalma de Carvalho Moreira Filho.   

Abstract

PURPOSE: To identify the main causes of visual impairment (VA <or= 0.2) within the population over 50 years of age examined in "Cataract Free Zone" projects sponsored by the University of Campinas from 1986 to 1995.
METHODS: A retrospective review of the ophthalmic forms used for 60,404 patients examined in 74 Cataract Projects was performed. Through mass media information, adults of the target region or city were asked to self-test their vision. Patients with VA <or= 0.2 in the better eye were to come to a visual acuity test. Using Snellen charts, visual acuity testing was done by trained auxiliaries and medical students. The positive cases were then examined by ophthalmologists Criteria were established for the classification of the diagnoses and statistical analysis was performed.
RESULTS: After the self-test of visual acuity, 60,404 patients came to have their visual acuity tested; 11,462 (18.97%) cases were considered positive and were submitted to complete eye examination; 5447 (42.7%) received spectacles for vision improvement, and 2704 (23.59%) had cataract surgery done. Other important causes of visual impairment were senile macular degeneration (5.4%) and glaucoma (4.02%).
CONCLUSION: The main causes of visual impairment were non-corrected refractive errors and senile cataract. Ophthalmic community-based campaigns to serve the older population are recommended in order to detect and treat the identified cases and to indicate possible changes in the health care system.

Entities:  

Mesh:

Year:  2003        PMID: 12607155     DOI: 10.1076/opep.10.1.15.13774

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  6 in total

1.  Prevalence and outcomes of cataract surgery in Brazil: the São Paulo eye study.

Authors:  Solange R Salomão; Francisco S Soares; Adriana Berezovsky; Arnaud Araújo-Filho; Marcia R K H Mitsuhiro; Sung E S Watanabe; Alisson V Carvalho; Gopal P Pokharel; Rubens Belfort; Leon B Ellwein
Journal:  Am J Ophthalmol       Date:  2009-05-05       Impact factor: 5.258

2.  Orthoptic Changes following Photorefractive Keratectomy.

Authors:  Zhale Rajavi; Nader Nassiri; Monir Azizzadeh; Alireza Ramezani; Mehdi Yaseri
Journal:  J Ophthalmic Vis Res       Date:  2011-04

3.  The prevalence of refractive errors in 6- to 15-year-old schoolchildren in Dezful, Iran.

Authors:  Reza Norouzirad; Hassan Hashemi; Abbasali Yekta; Fereidon Nirouzad; Hadi Ostadimoghaddam; Negareh Yazdani; Nooshin Dadbin; Ali Javaherforoushzadeh; Mehdi Khabazkhoob
Journal:  J Curr Ophthalmol       Date:  2015-11-06

4.  Prevalence and causes of visual impairment in a Brazilian population: the Botucatu Eye Study.

Authors:  Silvana Artioli Schellini; Shane R Durkin; Erika Hoyama; Flavio Hirai; Ricardo Cordeiro; Robert J Casson; Dinesh Selva; Carlos Roberto Padovani
Journal:  BMC Ophthalmol       Date:  2009-08-19       Impact factor: 2.209

5.  Influence of uncorrected refractive error and unmet refractive error on visual impairment in a Brazilian population.

Authors:  Fabio H Ferraz; José E Corrente; Paula Opromolla; Silvana A Schellini
Journal:  BMC Ophthalmol       Date:  2014-06-25       Impact factor: 2.209

6.  The use of telemedicine to support Brazilian primary care physicians in managing eye conditions: The TeleOftalmo Project.

Authors:  Aline Lutz de Araujo; Taís de Campos Moreira; Dimitris Rucks Varvaki Rados; Paula Blasco Gross; Cynthia Goulart Molina-Bastos; Natan Katz; Lisiane Hauser; Rodolfo Souza da Silva; Sabrina Dalbosco Gadenz; Rafael Gustavo Dal Moro; Felipe Cezar Cabral; Lucas Matturro; Cássia Garcia Moraes Pagano; Amanda Gomes Faria; Maicon Falavigna; Ana Célia da Silva Siqueira; Paulo Schor; Marcelo Rodrigues Gonçalves; Roberto Nunes Umpierre; Erno Harzheim
Journal:  PLoS One       Date:  2020-04-02       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.